Ho Sung Cho
Vice President, Biotherapeutics, Celgene
Since joining Celgene in 2014, Dr. Cho has served in a leadership role focused on integrating internal and external capabilities and programs to deliver transformative medicines based on recombinant DNA technologies. Dr. Cho is the site-head for Celgene San Diego Campus Point and serves on the executive team for the Immuno-oncology TCoE. Dr. Cho is a Protein Medicinal Chemist with over 25 years of experience in recombinant protein design, expression, purification, modification, and analysis.
Prior to joining the industry, Dr. Cho worked on the structural genomics project at the Lawrence Berkeley National Labs. He received his Ph. D. in Chemistry from the University of California at Berkeley.